The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
Versha Banerji(CancerCare Manitoba), Kimberly Stegmaier(Broad Institute)
Cited by 104
Related Papers
Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting
|Cancer Discovery|2016|632
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
|Nature Genetics|2004|269
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
|Journal of Clinical Investigation|2017|159